FDA Allows Use of Recombinant BCG Through Expanded Access Program

Posted on

A diverse group of smiling people in a medical setting, with a friendly doctor holding a sign saying “rBCG Approved!”. Background shows a poster with a bladder diagram and “New Hope” written. Easy Read icons like a checkmark and calendar visible.Recombinant BCG Offers Fresh Promise in Bladder Cancer Care The U.S. Food and Drug Administration (FDA) has approved a new version of the BCG treatment for bladder cancer. This updated treatment is called recombinant BCG (rBCG) and will be available through the Expanded Access Program. This approval is a major step forward. For years, there …

The post FDA Allows Use of Recombinant BCG Through Expanded Access Program appeared first on Disability Horizons.